Aslan Pharmaceuticals | D: Filing D
Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mitchell P. Kopin(4.4%),Daniel B. Asher(4.4%), etc.
Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(5.7%),Lind Global Partners II LLC(5.7%), etc.
Aslan Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-K2 HealthVentures Equity Trust LLC(5.2%),Parag Shah(5.2%), etc.
Aslan Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF Partners L.P.(9.99%),BVF Inc.(9.99%), etc.
Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-UBS Group AG directly and on behalf of certain subsidiaries.(8.91%)
Aslan Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(1.5%),Tang Capital Management, LLC(1.5%), etc.
Aslan Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(11.0%),Tang Capital Management, LLC(11.0%), etc.
Aslan Pharmaceuticals | D: Filing D
Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-K2 HealthVentures Equity Trust LLC(6.2%),Parag Shah(6.2%), etc.
Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BVF Partners L.P.(9.99%),BVF Inc.(9.99%), etc.
Aslan Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(7.8%),Tang Capital Management, LLC(7.8%), etc.
Aslan Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(0%),Roderick Wong(0%)
Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-TANG CAPITAL PARTNERS, LP(5.4%),Tang Capital Management, LLC(5.4%), etc.
Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-RTW Investments, LP(6.8%),Roderick Wong(6.8%)
Aslan Pharmaceuticals | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Aslan Pharmaceuticals | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
No Data